Will FDA approve any mRNA vaccine against prostate adenocarcinoma before 2028?
Health & MedicineOne-Off1yManifold MarketsNo KYCVerified resolution dataFairly calibratedCurrent community forecastNo 79.4%
Forecasters
3
Question type
binary
Methodology
Play-money forecasting platform
Source type
Forecast
Market data
Updated 2 hours ago
StaleFeb 21, 23, 8:25 PM UTCDec 31, 27, 10:59 PM UTC
Trends
Related Markets
Related questions for context, not a comparison of equivalent contracts.
Will FDA approve any mRNA vaccine against melanoma before 2028?
Manifold MarketsWill FDA approve any mRNA vaccine against any type of herpes simplex infection before 2028?
Manifold MarketsWill FDA approve any mRNA vaccine against any strain of influenza before 2028?
Manifold MarketsAny vaccine against Alzheimer's disease to be safe and effective by the end of 2027?
FutuurWill the FDA approve intismeran autogene (V940/mRNA-4157)?
KalshiFDA approves skin cancer vaccine by which date?
PolymarketRules
Resolves YES if the FDA grants full approval for the commercial sale of any mRNA-based vaccine for the treatment of prostate adenocarcinoma in the United States before January 1, 2028.
- This does not include emergency use authorization or other forms of limited authorization.
- Resolves NO otherwise.
Frequently asked questions
- What are the current odds for Will FDA approve any mRNA vaccine against prostate adenocarcinoma before 2028??
- Manifold Markets prices No at 79% as of September 8, 2026.
- When does Will FDA approve any mRNA vaccine against prostate adenocarcinoma before 2028? resolve?
- Will FDA approve any mRNA vaccine against prostate adenocarcinoma before 2028? is scheduled to resolve on December 31, 2027.
- How is Will FDA approve any mRNA vaccine against prostate adenocarcinoma before 2028? settled?
- Manifold Markets settles this market as follows: Resolves YES if the FDA grants full approval for the commercial sale of any mRNA-based vaccine for the treatment of prostate adenocarcinoma in the United States before January 1, 2028.